Figure 2From: Comparison of the Agilent, ROMA/NimbleGen and Illumina platforms for classification of copy number alterations in human breast tumorsPiecewise constant regression for chromosome 6. Detection of genomic aberrations using the PCF method for all platforms, shown for chromosome 6 for patient sample 146. Despite the great similarities in the overall size, structure and amplitude of aberrations, several minor variations are seen.Back to article page